Skip to content
Open access

Facilitating the interpretation of individual patient-reported outcomes: thresholds for clinical importance for the EORTC colorectal cancer module (EORTC QLQ-CR29).

Nov 2026 · Journal of Clinical Epidemiology · pp. 112583 · 0 citations
Medicine

Abstract

Objective

Patient-reported outcomes (PROs) for individual patients with colorectal cancer (CRC) can be interpreted by using PRO scores with thresholds for clinical importance (TCIs). This study established TCIs for the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Colorectal Cancer 29 (EORTC QLQ-CR29), a widely used PRO measure (PROM) in research and practice. STUDY

Design

AND

Setting

Patients with CRC from six countries completed the EORTC QLQ-CR29. To establish TCIs, patients completed anchor questions assessing limitations in daily life, need for help and/or care, and patient and partner/family worries for each item. Diagnostic accuracy for each scale was then determined using ROC analysis, along with the sensitivity and specificity of the TCIs.

Results

In total, 240 patients (mean age: 62.2, 53% men) completed the EORTC QLQ-CR29 and anchor items on clinical importance. Area Under the ROC (AUC), a measure of diagnostic accuracy, was 0.80 or higher for 17 of the 22 QLQ-CR29 scales, with lower values observed for urinary frequency (0.79), blood and mucus in stool (0.79), dyspareunia (0.77), stoma care problems (0.74), and sexual interest (0.66). Sensitivity and specificity values for all TCIs ranged from 0.59 to 1.00, except for the sexual interest scale with a sensitivity of 0.35.

Conclusion

TCIs for the EORTC QLQ-CR29 supporting the interpretation of absolute PROMs scores of individual patients were established. These will facilitate the use of the QLQ-CR29 in clinical practice, supporting the identification of clinically important health domains of individual patients with CRC from absolute PROM scores.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.